WWP
SPRO icon

WR Wealth Planners’s Spero Therapeutics SPRO Stock Holding History

WR Wealth Planners’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.68K Hold
2,600
– – ﹤0.01% 806
2024
Q3 		$3.48K Hold
2,600
– – ﹤0.01% 802
2024
Q2 		$3.38K Hold
2,600
– – ﹤0.01% 783
2024
Q1 		$4.47K Buy
+2,600
New +$4.08K ﹤0.01% 739
2023
Q4 		– Sell
-2,600
Closed -$3.15K – 764
2023
Q3 		$3.15K Hold
2,600
– – ﹤0.01% 727
2023
Q2 		$3.77K Hold
2,600
– – ﹤0.01% 717
2023
Q1 		$3.77K Buy
+2,600
New +$4.35K ﹤0.01% 720

Other funds holding SPRO

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WR Wealth Planners's SPRO Position: Q4 2024 in Review

WR Wealth Planners held its Spero Therapeutics (SPRO) position steady in Q4 2024 at 2,600 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

WR Wealth Planners first reported a position in SPRO in Q1 2023 and has held it in 7 quarters since. The position peaked at $4.47K in Q1 2024. 50 funds tracked by Wall St. Rank hold SPRO as of Q4 2024.

  • WR Wealth Planners held 2,600 shares of Spero Therapeutics worth $2.68K as of Q4 2024.
  • WR Wealth Planners left its Spero Therapeutics share count unchanged in Q4 2024.
  • Spero Therapeutics made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #806 holding.
  • WR Wealth Planners first reported a position in Spero Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • WR Wealth Planners's Spero Therapeutics position peaked at $4.47K in Q1 2024.
  • 50 funds tracked by Wall St. Rank held Spero Therapeutics as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.